ARTeSYN Biosolutions Expands Manufacturing Capability in Waterford
11 November, 2019
Manufacturer of single-use components & systems within the biotech industry to create 50 new jobs and invest €1M in manufacturing & clean room facilities.
Minister for Training, Skills, Innovation, Research and Development John Halligan TD announced on Friday that ARTeSYN Biosolutions, the manufacturer of single-use solutions for biopharma processing, is to significantly expand its Waterford operations by adding 50 new roles in Production, Engineering, Customer Service and Research & Development over the next 3 years at its facilities in the Six Cross Roads Business Park, Waterford. The expansion of the site increases the company’s consumables and overall production capacity by an additional 2200 ft².
The expansion is supported by the Irish Government through IDA Ireland.
The company which has invested over €1M in its manufacturing & cleanroom facilities currently employs 24 people in Waterford. Due to the increase in demand for its components & systems by global companies in the biopharma sector, ARTeSYN Biosolutions has identified Waterford as a key site from which to supply its growing customer base.
ARTeSYN Biosolutions, a privately-held company, is a fast-expanding brand providing single-use solutions to the biotechnology & cell and gene therapy market. ARTeSYN has several locations in the US and over the last few years has expanded to Ireland, Estonia & Asia. The global team shares 30+ years of experience in building simple and effective components and systems. Our goal is to enable not 10%, but 10x more efficient manufacturing and ultimately ease access to essential medicines globally. In essence, we have created a series of solutions targeting the voids and expanding the possibilities in the existing single-use space. Our single-use valves, fully disposable valve liners, instruments, flow management technology, and automated process systems, enable creative approaches in their most advanced forms for common industry problems.
For more information click HERE.